Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-02-12 Sale | 2024-02-13 6:14 pm | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 28,600 | $4.6204 | $132,143 | 169,938 (Direct) | View |
2024-01-03 Sale | 2024-01-08 06:04 am | G1 Therapeutics Inc. | GTHX | Umstead John W. V Chief Financial Officer | 743 | $3.0925 | $2,298 | 204,943 (Direct) | View |
2024-01-03 Sale | 2024-01-08 06:03 am | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 3,740 | $3.0849 | $11,537 | 244,438 (Direct) | View |
2024-01-03 Sale | 2024-01-08 06:03 am | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 2,413 | $3.1189 | $7,526 | 154,152 (Direct) | View |
2024-01-03 Sale | 2024-01-08 06:02 am | G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. President and CEO | 11,686 | $3.1189 | $36,447 | 690,894 (Direct) | View |
2024-01-03 Sale | 2024-01-08 06:02 am | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 4,081 | $3.0877 | $12,601 | 207,234 (Direct) | View |
2024-01-03 Sale | 2024-01-08 06:00 am | G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer | 3,740 | $3.0849 | $11,537 | 178,138 (Direct) | View |
2024-01-02 Sale | 2024-01-02 7:44 pm | G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. President and CEO | 32,983 | $3.2746 | $108,006 | 400,580 (Direct) | View |
2023-12-11 Sale | 2023-12-13 4:45 pm | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 33,839 | $3.4139 | $115,522 | 164,978 (Direct) | View |
2023-08-08 Sale | 2023-08-10 4:11 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 60,000 | $1.9996 | $119,974 | 358,286 (Direct) | View |
2023-07-05 Sale | 2023-07-07 4:08 pm | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 355 | $2.4537 | $871 | 55,945 (Direct) | View |
2023-07-05 Sale | 2023-07-07 4:08 pm | G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer | 1,361 | $2.4537 | $3,339 | 70,078 (Direct) | View |
2023-07-05 Sale | 2023-07-07 4:08 pm | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 1,361 | $2.4537 | $3,339 | 136,378 (Direct) | View |
2023-07-05 Sale | 2023-07-07 4:07 pm | G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. President and CEO | 2,719 | $2.4537 | $6,672 | 433,563 (Direct) | View |
2023-01-04 Sale | 2023-01-05 8:26 pm | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 2,368 | $5.5238 | $13,080 | 102,420 (Direct) | View |
2023-01-04 Sale | 2023-01-05 8:26 pm | G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer | 2,368 | $5.5238 | $13,080 | 72,139 (Direct) | View |
2023-01-04 Sale | 2023-01-05 8:25 pm | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 820 | $5.5756 | $4,572 | 53,400 (Direct) | View |
2023-01-04 Sale | 2023-01-05 8:25 pm | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 2,368 | $5.5238 | $13,080 | 138,439 (Direct) | View |
2023-01-04 Sale | 2023-01-05 8:25 pm | G1 Therapeutics Inc. | GTHX | Hanson James S. General Counsel | 2,368 | $5.5238 | $13,080 | 76,787 (Direct) | View |
2023-01-03 Sale | 2023-01-05 8:23 pm | G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. President and CEO | 37,626 | $5.8129 | $218,714 | 437,582 (Direct) | View |
2022-10-18 Sale | 2022-10-20 4:05 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 15,000 | $11.7 | $175,490 | 173,286 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-02-12 Exercise | 2024-02-13 6:14 pm | N/A 2025-02-27 | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 28,600 | $0 | 169,938 (Direct) | View |
2024-02-12 Exercise | 2024-02-13 6:14 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 28,600 | $0.3 | 169,938 (Direct) | View |
2024-01-03 Option Award | 2024-01-08 06:04 am | N/A 2034-01-03 | G1 Therapeutics Inc. | GTHX | Umstead John W. V Chief Financial Officer | 111,800 | $0 | 204,943 (Direct) | View |
2024-01-03 Option Award | 2024-01-08 06:03 am | N/A 2034-01-03 | G1 Therapeutics Inc. | GTHX | Thomas Monica R. General Counsel | 83,850 | $0 | 134,026 (Direct) | View |
2024-01-03 Option Award | 2024-01-08 06:03 am | N/A 2034-01-03 | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 111,800 | $0 | 244,438 (Direct) | View |
2024-01-03 Option Award | 2024-01-08 06:03 am | N/A 2034-01-03 | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 100,620 | $0 | 154,152 (Direct) | View |
2024-01-03 Option Award | 2024-01-08 06:02 am | N/A 2034-01-03 | G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. President and CEO | 302,000 | $0 | 690,894 (Direct) | View |
2024-01-03 Option Award | 2024-01-08 06:02 am | N/A 2034-01-03 | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 134,160 | $0 | 207,234 (Direct) | View |
2024-01-03 Option Award | 2024-01-08 06:00 am | N/A 2034-01-03 | G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer | 111,800 | $0 | 178,138 (Direct) | View |
2023-12-11 Exercise | 2023-12-13 4:45 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 21,439 | $0.39 | 164,978 (Direct) | View |
2023-12-11 Exercise | 2023-12-13 4:45 pm | N/A 2025-02-27 | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 33,839 | $0 | 164,978 (Direct) | View |
2023-12-11 Exercise | 2023-12-13 4:45 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 12,400 | $0.3 | 164,978 (Direct) | View |
2023-08-08 Exercise | 2023-08-10 4:11 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 57,286 | $0.39 | 358,286 (Direct) | View |
2023-08-08 Exercise | 2023-08-10 4:11 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 60,000 | $0 | 358,286 (Direct) | View |
2023-08-08 Exercise | 2023-08-10 4:11 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 2,714 | $0.3 | 358,286 (Direct) | View |
2023-06-15 Option Award | 2023-06-16 4:07 pm | N/A 2033-06-15 | G1 Therapeutics Inc. | GTHX | Sharpless Norman Director | 40,000 | $0 | 40,000 (Direct) | View |
2023-06-15 Option Award | 2023-06-16 4:07 pm | N/A 2033-06-15 | G1 Therapeutics Inc. | GTHX | Flowers Cynthia Louise Director | 40,000 | $0 | 55,889 (Direct) | View |
2023-06-15 Option Award | 2023-06-16 4:07 pm | N/A 2033-06-15 | G1 Therapeutics Inc. | GTHX | MUIR GLENN P Director | 40,000 | $0 | 225,358 (Direct) | View |
2023-06-15 Option Award | 2023-06-16 4:06 pm | N/A 2033-06-15 | G1 Therapeutics Inc. | GTHX | Lee Jacks Director | 40,000 | $0 | 40,000 (Direct) | View |
2023-06-15 Option Award | 2023-06-16 4:06 pm | N/A 2033-06-15 | G1 Therapeutics Inc. | GTHX | Secor Alicia Director | 40,000 | $0 | 50,000 (Direct) | View |
2023-06-15 Option Award | 2023-06-16 4:06 pm | N/A 2033-06-15 | G1 Therapeutics Inc. | GTHX | Nicholson Garry A Director | 40,000 | $0 | 54,389 (Direct) | View |
Ownership | 2023-05-24 4:41 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Thomas Monica R. General Counsel | 0 | $0 | 176 (Direct) | View |
2023-05-22 Option Award | 2023-05-24 4:41 pm | N/A 2033-05-22 | G1 Therapeutics Inc. | GTHX | Thomas Monica R. General Counsel | 200,000 | $0 | 200,176 (Direct) | View |
2023-05-10 Option Award | 2023-05-12 4:20 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer | 35,000 | $0 | 71,439 (Direct) | View |
2023-05-10 Option Award | 2023-05-12 4:20 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 35,000 | $0 | 77,155 (Direct) | View |
2023-05-10 Option Award | 2023-05-12 4:19 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 35,000 | $0 | 137,739 (Direct) | View |
2023-05-10 Option Award | 2023-05-12 4:19 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Umstead John V. Chief Financial Officer | 35,000 | $0 | 93,886 (Direct) | View |
2023-05-10 Option Award | 2023-05-12 4:19 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 35,000 | $0 | 56,300 (Direct) | View |
2023-05-10 Option Award | 2023-05-12 4:16 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. President and CEO | 160,000 | $0 | 436,282 (Direct) | View |
2023-03-15 Option Award | 2023-03-17 4:20 pm | N/A 2033-03-15 | G1 Therapeutics Inc. | GTHX | Umstead John V. Chief Financial Officer | 150,000 | $0 | 158,886 (Direct) | View |
Ownership | 2023-03-17 4:10 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Umstead John V. Chief Financial Officer | 0 | $0 | 42,136 (Direct) | View |
2023-01-03 Option Award | 2023-01-05 8:26 pm | N/A 2033-01-03 | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 66,900 | $0 | 102,420 (Direct) | View |
2023-01-03 Option Award | 2023-01-05 8:26 pm | N/A 2033-01-03 | G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer | 53,600 | $0 | 72,139 (Direct) | View |
2023-01-03 Option Award | 2023-01-05 8:25 pm | N/A 2033-01-03 | G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer | 48,200 | $0 | 53,400 (Direct) | View |
2023-01-03 Option Award | 2023-01-05 8:25 pm | N/A 2033-01-03 | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 53,600 | $0 | 138,439 (Direct) | View |
2023-01-03 Option Award | 2023-01-05 8:25 pm | N/A 2033-01-03 | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 61,700 | $0 | 83,255 (Direct) | View |
2023-01-03 Option Award | 2023-01-05 8:25 pm | N/A 2033-01-03 | G1 Therapeutics Inc. | GTHX | Hanson James S. General Counsel | 53,600 | $0 | 76,787 (Direct) | View |
2023-01-03 Option Award | 2023-01-05 8:23 pm | N/A 2033-01-03 | G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. President and CEO | 242,000 | $0 | 437,582 (Direct) | View |
2022-12-15 Exercise | 2022-12-16 4:12 pm | N/A 2025-02-27 | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 14,000 | $0 | 128,207 (Direct) | View |
2022-12-15 Exercise | 2022-12-16 4:12 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 14,000 | $0.3 | 128,207 (Direct) | View |
2022-10-18 Exercise | 2022-10-20 4:05 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 15,000 | $0.39 | 173,286 (Direct) | View |
2022-10-18 Exercise | 2022-10-20 4:05 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 15,000 | $0 | 173,286 (Direct) | View |